Loading cancer entity…
Loading cancer entity…
Clinical trials
14 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (0)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01008501 | Study of the Genetic and Epigenetic Causes of Recurrent Hydatidiform Moles | active not recruiting | — | 100 | Baylor College of MedicineOTHER | 1 | Apr 23, 2026 | clinicaltrials |
| NCT03785574 | Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule | recruiting | N/A | 30 | Women's Hospital School Of Medicine Zhejiang UniversityOTHER | 1 | Mar 16, 2026 | clinicaltrials |
| NCT07202728 | A Multi-center Cohort Study of Hydatidiform Mole in China (CN-HM-01)(CN-HM-01) | recruiting | — | 1,489 | Obstetrics & Gynecology Hospital of Fudan UniversityOTHER | 1 | Oct 2, 2025 | clinicaltrials |
| NCT04562558 | Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia | active not recruiting | N/A | 228 | xiang yangOTHER | 1 | Aug 11, 2025 | clinicaltrials |
| NCT05516810 | The Accuracy of Ultrasound Diagnosis of Hydatidiform Moles | unknown | — | 500 | King's College Hospital NHS TrustOTHER | 1 | Jun 11, 2024 | clinicaltrials |
| NCT05637892 | A Cohort Study of Hydatidiform Mole | not yet recruiting | — | 800 | Women's Hospital School Of Medicine Zhejiang UniversityOTHER | 0 | Dec 8, 2022 | clinicaltrials |
| NCT01535053 | Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia | completed | Phase 3 | 57 | GOG FoundationNETWORK | 5 | Aug 12, 2022 | clinicaltrials |
| NCT04756713 | Second Uterine Evacuation for Low-risk Gestational Trophoblastic Neoplasia(ReCure) | unknown | Phase 3 | 150 | Brigham and Women's HospitalOTHER | 1 | May 27, 2022 | clinicaltrials |
| NCT01984099 | RCT on the Efficacy of Methotrexate for the Prevention of GTD | completed | Phase 3 | 99 | University of the PhilippinesOTHER | 1 | Apr 17, 2020 | clinicaltrials |
| NCT00003702 | Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia | completed | Phase 3 | 240 | Gynecologic Oncology GroupNETWORK | 1 | May 15, 2018 | clinicaltrials |
| NCT00521118 | Second Curettage in Treating Patients With Persistent Non-metastatic Gestational Trophoblastic Tumors | completed | Phase 2 | 64 | Gynecologic Oncology GroupNETWORK | 2 | Aug 24, 2017 | clinicaltrials |
| NCT02892877 | The French National Reference Centre of GTD(French GTDC) | recruiting | — | 25,500 | Hospices Civils de LyonOTHER | 1 | Sep 8, 2016 | clinicaltrials |
| NCT01630954 | A Comparison of Single Versus Double Evacuation for Treatment of Hydatidiform Mole | unknown | Phase 4 | 120 | Nilratan Sircar Medical CollegeOTHER_GOV | 1 | Mar 23, 2016 | clinicaltrials |
| NCT00190918 | A Trial for Patients With Gestational Trophoblastic Disease | completed | Phase 2 | 50 | Eli Lilly and CompanyINDUSTRY | 1 | Aug 9, 2007 | clinicaltrials |
Data updated 22 days agoSource updated Apr 23, 2026source: clinicaltrials